Mirati Therapeutics Reports Second Quarter 2017 Financial Results Post author:Sam Post published:August 3, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Gene Therapy Firm Files for $35 Million IPO August 21, 2017 Phase I Clinical Data Of ABX464, ABIVAX's First-In-Class Anti-HIV Drug, Published In Two Articles In Peer-Reviewed Journals February 2, 2017 Tiny OncoSec Surges on Promising Phase II Melanoma Data November 7, 2017
Phase I Clinical Data Of ABX464, ABIVAX's First-In-Class Anti-HIV Drug, Published In Two Articles In Peer-Reviewed Journals February 2, 2017